Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Non-inferiority Study of Induction Chemotherapy Followed by IMRT Alone Versus Induction Chemotherapy Followed by IMRT Plus Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

NCT02434614 is registered in ClinicalTrials.gov with Wei Jiang as lead sponsor.

NCT NCT02434614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02434614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Non-inferiority Study of Induction Chemotherapy Followed by IMRT Alone Versus Induction Chemotherapy Followed by IMRT Plus Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Lead sponsor
Wei Jiang
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2015
Completion date
December 31, 2021
Enrollment
440 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal carcinoma